Table 2.
Summary of Siglecs in CNS.
| Type | Ligands | Cell type/ Subcellular location | Functions | References | |
|---|---|---|---|---|---|
| Siglec-1 (sialoadhesin, CD169) | α2–3, α2–6 sialic acid residues | Microglia | • Plasma membrane | • Cell-cell interaction | Macauley et al. (2014) and Groh et al. (2016) |
| Siglec-3 (CD33) | α2–6, α2–3 sialic acid residues | Microglia | • Plasma membrane | • Modulation of microglial phagocytosis activity | Griciuc et al. (2013) and Macauley et al. (2014) |
| Siglec-4 (MAG) | α2–3, α2–6 sialic acid residues | On myelin sheath, produced by oligodendrocytes | • Inner-most, myelin periaxonal membrane | • Myelin-axon interaction, maintaining long-term axon stability | Sun et al. (2004), Huang et al. (2012) and Macauley et al. (2014) |
| Siglec-E | α2–3, α2–6, α2–8 sialic acid residues | Microglia | • Plasma membrane | • Inhibition of inflammation, ROS production and phagocytosis | Claude et al. (2013) and Macauley et al. (2014) |
| Siglec-F | α2–3 sialic acid residues | Microglia | • Plasma membrane | • Inhibition of phagocytosis | Wielgat and Braszko (2012) and Macauley et al. (2014) |
| Siglec-H | Abnormal sialic acid residues in glioma | Microglia | • Plasma membrane | • Promotion of phagocytosis | Kopatz et al. (2013) and Macauley et al. (2014) |
| Siglec-11 | α2–8 sialic acid residues | Microglia | • Plasma membrane | • Inhibition of inflammation and phagocytosis | Wang and Neumann (2010), Wang X. et al. (2012) and Macauley et al. (2014) |
| Siglec-16 | α2–8 sialic acid residues | Microglia | • Plasma membrane | • No functional data | Wang X. et al. (2012) and Macauley et al. (2014) |